Missy Clyne Diaz  |  April 28, 2015

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

tipped-pill-bottleThe federal judge overseeing the expansive multidistrict litigation of hundreds of Xarelto bleeding lawsuits has issued an order setting a so-called “Science Day,” where lawyers for both the plaintiffs and the defendants will address scientific and medical issues relevant to the cases.

U.S. District Judge Eldon Fallon in the U.S. District Court in the Eastern District of Louisiana has set aside June 11 for the parties to address pertinent information expected to be raised in the cases. Litigants accuse Xarelto manufacturer Janssen Pharmaceuticals (a division of Johnson & Johnson) of failing to provide adequate warnings about the risk of severe Xarelto injury, including irreversible bleeding and the lack of an approved reversal agent for the new-generation blood-thinner.

Xarelto “Science Day”

“Science Day” presentations typically take place in complex pharmaceutical litigation that involves multiple claims of a similar nature. It allows for each of the parties to present to the court its information in a non-adversarial setting well in advance of a trial.

The Xarelto Science Day is likely to include information about blood thinners and how they prevent blood clots and strokes as well as information and data about serious injuries and deaths from Xarelto and the bleeding risks associated with the medication.

What is Xarelto?

Since receiving FDA approval in 2011, Xarelto has been widely prescribed to prevent blood clots in patients suffering from atrial fibrillation (arrhythmia of the heart), deep vein thrombosis (blood clots deep within the body), pulmonary embolism (blood clots in the lungs), stroke, and patients who have recently undergone a knee or hip replacement surgery.

It is viewed as an alternative to Warfarin (Coumadin), a blood thinner that has been used in the United States for 50 years. Severe internal bleeding and death are Xarelto’s most commonly reported side effects, but others include thrombosis (blood clots), decreased hemoglobin (a substance that carries oxygen in red blood cells), cerebrovascular accidents (an event that leads to a cerebral hemorrhage), hematoma (a semisolid mass in the blood), peripheral edema (swelling of the lower limbs), and dyspnea (difficulty breathing).

Johnson & Johnson and Bayer have marketed Xarelto as a superior blood thinner alternative to Coumadin for anticoagulant therapy. Patients taking Coumadin must adhere to dietary restrictions and regularly have their blood checked.

But internal bleeding episodes while on Coumadin can be reversed by administering vitamin K. No approved antidote exists to reverse Xarelto bleeding.

Xarelto Lawsuits

Plaintiffs who have filed Xarelto lawsuits claim that they were not made aware that Xarelto bleeding events could not be reversed similarly to Coumadin, with vitamin K.

Xarelto is in the same class of drugs as Pradaxa, another of the newer anticoagulants which is also a defendant in a slew of lawsuits where plaintiffs have alleged bleeding complications. Pradaxa manufacturers reached a $650 million settlement with thousands of plaintiffs.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Xarelto attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Xarelto class action lawsuit is best for you. [In general, Xarelto lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

Get Help – It’s Free

Join a Free Xarelto Class Action Lawsuit Investigation

If you or a loved one took Xarelto (rivaroxaban) and suffered injuries such as uncontrollable internal bleeding, gastrointestinal bleeding, hemorrhaging, deep vein thrombosis or pulmonary embolism, you may have a legal claim. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

Oops! We could not locate your form.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.